Abstract
Many rare kidney disorders exhibit a monogenic, Mendelian pattern of inheritance. Population-based genetic studies have identified many genetic variants associated with an increased risk of developing common kidney diseases. Strongly associated variants have potential clinical uses as predictive markers and may advance our understanding of disease pathogenesis. These principles are elegantly illustrated by a region within chromosome 22q12 that has a strong association with common forms of kidney disease. Researchers had identified DNA sequence variants in this locus that were highly associated with an increased prevalence of common chronic kidney diseases in people of African ancestry. Initial research concentrated on MYH9 as the most likely candidate gene; however, population-based whole-genome analysis enabled two independent research teams to discover more strongly associated mutations in the neighboring APOL1 gene. The powerful evolutionary selection pressure of an infectious pathogen in West Africa favored the spread of APOL1 variants that protect against a lethal form of African sleeping sickness but are highly associated with an increased risk of kidney disease. We describe the data sources, process of discovery, and reasons for initial misidentification of the candidate gene, as well as the lessons that can be learned for future population genetics research.
Key Points
-
Population genetic studies have identified loci that confer susceptibility to many common forms of kidney disease; however, ascertaining the underlying biologic mechanisms is often a challenge
-
Linkage disequilibrium, admixture and genetic variation are some of the key factors underlying the success of population-based approaches to the discovery of genes that are associated with disease
-
Population genetics research identified a region on chromosome 22q12 containing DNA sequence variants associated with a predisposition to many diabetes-unrelated forms of kidney disease in African and Hispanic Americans
-
The MYH9 gene was initially thought to harbor these mutations, but the neighboring gene APOL1 was subsequently identified as being more strongly associated with kidney disease
-
APOL1 mutations confer protection against sleeping sickness, which might explain the high prevalence of kidney disease in persons whose ancestry links them to geographic regions with past trypanosomal exposure
-
APOL1 genotyping has potential clinical applications for management of hypertension in individuals with kidney disease, management of patients with HIV-associated nephropathy, and for donors and recipients in kidney transplantation
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tryggvason, K., Patrakka, J. & Wartiovaara, J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N. Engl. J. Med. 354, 1387–1401 (2006).
Löwik, M. M., Groenen, P. J., Levtchenko, E. N., Monnens, L. A. & van den Heuvel, L. P. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis—a review. Eur. J. Pediatr. 168, 1291–1304 (2009).
Hildebrandt, F. Genetic kidney diseases. Lancet 375, 1287–1295 (2010).
Harris, P. C. 2008 Homer W. Smith Award: insights into the pathogenesis of polycystic kidney disease from gene discovery. J. Am. Soc. Nephrol. 20, 1188–1198 (2009).
Chadha, V. & Alon, U. S. Hereditary renal tubular disorders. Semin. Nephrol. 29, 399–411 (2009).
Welling, P. A., Chang, Y. P., Delpire, E. & Wade, J. B. Multigene kinase network, kidney transport, and salt in essential hypertension. Kidney Int. 77, 1063–1069 (2010).
Magen, D. et al. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N. Engl. J. Med. 362, 1102–1109 (2010).
Virkki, L. V., Forster, I. C., Hernando, N., Biber, J. & Murer, H. Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa. J. Bone Miner. Res. 18, 2135–2141 (2003).
Lapointe, J. Y. et al. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int. 69, 2261–2267 (2006).
Prié, D. et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N. Engl. J. Med. 347, 983–991 (2002).
Kestenbaum, B. et al. Common genetic variants associate with serum phosphorus concentration. J. Am. Soc. Nephrol. 21, 1223–1232 (2010).
Köttgen, A. et al. New loci associated with kidney function and chronic kidney disease. Nat. Genet. 42, 376–384 (2010).
Jeck, N. et al. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R782–R795 (2005).
Adeyemo, A. et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 5, e1000564 (2009).
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
Jin, H. S. et al. Genetic variations in the sodium balance-regulating genes ENaC, NEDD4L, NDFIP2 and USP2 influence blood pressure and hypertension. Kidney Blood Press. Res. 33, 15–23 (2010).
Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677–687 (2009).
Lifton, R. P. Individual genomes on the horizon. N. Engl. J. Med. 362, 1235–1236 (2010).
Cirulli, E. T. & Goldstein, D. B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet. 11, 415–425 (2010).
Bostrom, M. A. et al. Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA. Hum. Genet. 128, 195–204 (2010).
Craig, D. W., Millis, M. P. & DiStefano, J. K. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes. Diabet. Med. 26, 1090–1098 (2009).
Kao, W. H. et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 40, 1185–1192 (2008).
Kopp, J. B. et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet. 40, 1175–1184 (2008).
Köttgen, A. et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. 41, 712–717 (2009).
Divers, J. & Freedman, B. I. Susceptibility genes in common complex kidney disease. Curr. Opin. Nephrol. Hypertens. 19, 79–84 (2010).
McKnight, A. J., Currie, D. & Maxwell, A. P. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders. J. Pathol. 220, 198–216 (2010).
Köttgen, A. Genome-wide association studies in nephrology research. Am. J. Kidney Dis. 56, 743–758 (2010).
Estrella, M. M., Sperati, C. J., Kao, W. H. & Parekh, R. S. Genetic epidemiology of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 19, 283–291 (2010).
Gudbjartsson, D. F. et al. Association of variants at UMOD with chronic kidney disease and kidney stones—role of age and comorbid diseases. PLoS Genet. 6, e1001039 (2010).
Vylet'al, P. et al. Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int. 70, 1155–1169 (2006).
Hart, T. C. et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J. Med. Genet. 39, 882–892 (2002).
Rampoldi, L. et al. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum. Mol. Genet. 12, 3369–3384 (2003).
Singh, N., Nainani, N., Arora, P. & Venuto, R. C. CKD in MYH9-related disorders. Am. J. Kidney Dis. 54, 732–740 (2009).
Bostrom, M. A. & Freedman, B. I. The spectrum of MYH9-associated nephropathy. Clin. J. Am. Soc. Nephrol. 5, 1107–1113 (2010).
Tzur, S. et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet. 128, 345–350 (2010).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African-Americans. Science 329, 841–845 (2010).
Behar, D. M. et al. The genome-wide structure of the Jewish people. Nature 466, 238–242 (2010).
Reich, D., Thangaraj, K., Patterson, N., Price, A. L. & Singh, L. Reconstructing Indian population history. Nature 461, 489–494 (2009).
Oleksyk, T. K., Smith, M. W. & O'Brien, S. J. Genome-wide scans for footprints of natural selection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365, 185–205 (2010).
Grossman, S. R. et al. A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327, 883–886 (2010).
Sabeti, P. C. et al. Genome-wide detection and characterization of positive selection in human populations. Nature 449, 913–918 (2007).
Durbin, R. M. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010).
Weiner, M. P., Gabriel, S. B. & Stephens, J. C. (eds) Genetic Variation: A Laboratory Manual (Cold Spring Harbour Laboratory Press, New York, 2007).
Feero, W. G., Guttmacher, A. E. & Collins, F. S. Genomic medicine–an updated primer. N. Engl. J. Med. 362, 2001–2011 (2010).
Jorde, L. B. & Wooding, S. P. Genetic variation, classification and 'race'. Nat. Genet. 36 (Suppl.), S28–S33 (2004).
Goldstein, D. B. Common genetic variation and human traits. N. Engl. J. Med. 360, 1696–1698 (2009).
Templeton, A. R. Haplotype trees and modern human origins. Am. J. Phys. Anthropol. 128 (Suppl.), 33–59 (2005).
Wall, J. D. & Pritchard, J. K. Haplotype blocks and linkage disequilibrium in the human genome. Nat. Rev. Genet. 4, 587–597 (2003).
Crawford, D. C. & Nickerson, D. A. Definition and clinical importance of haplotypes. Annu. Rev. Med. 56, 303–320 (2005).
Musunuru, K. et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363, 2220–2227 (2010).
Jorde, L. B. Linkage disequilibrium as a gene-mapping tool. Am. J. Hum. Genet. 56, 11–14 (1995).
Collins, A. Allelic association: linkage disequilibrium structure and gene mapping. Mol. Biotechnol. 41, 83–89 (2009).
Orr, N. & Chanock, S. Common genetic variation and human disease. Adv. Genet. 62, 1–32 (2008).
Altshuler, D., Daly, M. J. & Lander, E. S. Genetic mapping in human disease. Science 322, 881–888 (2008).
Reich, D. E. & Lander, E. S. On the allelic spectrum of human disease. Trends Genet. 17, 502–510 (2001).
Wang, W. Y., Barratt, B. J., Clayton, D. G. & Todd, J. A. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6, 109–118 (2005).
Bodmer, W. & Bonilla, C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40, 695–701 (2008).
Dickson, S. P., Wang, K., Krantz, I., Hakonarson, H. & Goldstein, D. B. Rare variants create synthetic genome-wide associations. PLoS Biol. 8, e1000294 (2010).
McCarthy, M. I. et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356–369 (2008).
Wang, K. et al. Interpretation of association signals and identification of causal variants from genome-wide association studies. Am. J. Hum. Genet. 86, 730–742 (2010).
Hindorff, L. A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362–9367 (2009).
Manolio, T. A. Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 363, 166–176 (2010).
Galvan, A., Ioannidis, J. P. & Dragani, T. A. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet. 26, 132–141 (2010).
Price, A. L., Zaitlen, N. A., Reich, D. & Patterson, N. New approaches to population stratification in genome-wide association studies. Nat. Rev. Genet. 11, 459–463 (2010).
Weale, M. E. Quality control for genome-wide association studies. Methods Mol. Biol. 628, 341–372 (2010).
Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747–753 (2009).
Patterson, N. et al. Methods for high-density admixture mapping of disease genes. Am. J. Hum. Genet. 74, 979–1000 (2004).
Hoggart, C. J., Shriver, M. D., Kittles, R. A., Clayton, D. G. & McKeigue, P. M. Design and analysis of admixture mapping studies. Am. J. Hum. Genet. 74, 965–978 (2004).
Shlush, L. I. et al. Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers. BMC Med. Genomics 3, 47 (2010).
Ferguson, R., Grim, C. E. & Opgenorth, T. J. A familial risk of chronic renal failure among blacks on dialysis? J. Clin. Epidemiol. 41, 1189–1196 (1988).
Freedman, B. I., Spray, B. J., Tuttle, A. B. & Buckalew, V. M. Jr. The familial risk of end-stage renal disease in African Americans. Am. J. Kidney Dis. 21, 387–393 (1993).
Satko, S. G., Sedor, J. R., Iyengar, S. K. & Freedman, B. I. Familial clustering of chronic kidney disease. Semin. Dial. 20, 229–236 (2007).
Freedman, B. I., Soucie, J. M., Stone, S. M. & Pegram, S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am. J. Kidney Dis. 34, 254–258 (1999).
United States Renal Data System. Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2008).
Ward, M. M. Socioeconomic status and the incidence of ESRD. Am. J. Kidney Dis. 51, 563–572 (2008).
Powe, N. R. To have and have not: health and health care disparities in chronic kidney disease. Kidney Int. 64, 763–772 (2003).
Lucas, G. M. et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J. Infect. Dis. 197, 1548–1557 (2008).
Winkler, C. Is there a genetic basis for health disparities in human immunodeficiency virus disease? Mt Sinai J. Med. 77, 149–159 (2010).
Bryc, K. et al. Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc. Natl Acad. Sci. USA 107, 786–791 (2010).
Salas, A., Carracedo, A., Richards, M. & Macaulay, V. Charting the ancestry of African Americans. Am. J. Hum. Genet. 77, 676–680 (2005).
Tishkoff, S. A. et al. The genetic structure and history of Africans and African Americans. Science 324, 1035–1044 (2009).
Bercovici, S., Geiger, D., Shlush, L., Skorecki, K. & Templeton, A. Panel construction for mapping in admixed populations via expected mutual information. Genome Res. 18, 661–667 (2008).
Macaulay, V. et al. Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes. Science 308, 1034–1036 (2005).
Tian, C., Gregersen, P. K. & Seldin, M. F. Accounting for ancestry: population substructure and genome-wide association studies. Hum. Mol. Genet. 17, R143–R150 (2008).
Tang, H., Peng, J., Wang, P. & Risch, N. J. Estimation of individual admixture: analytical and study design considerations. Genet. Epidemiol. 28, 289–301 (2005).
Price, A. L. et al. A genomewide admixture map for Latino populations. Am. J. Hum. Genet. 80, 1024–1036 (2007).
Bryc, K. et al. Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc. Natl Acad. Sci. USA 107 (Suppl. 2), 8954–8961 (2010).
Salas, A. et al. The African diaspora: mitochondrial DNA and the Atlantic slave trade. Am. J. Hum. Genet. 74, 454–465 (2004).
Kopp, J. B. Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism? Kidney Int. 78, 130–133 (2010).
Freedman, B. I. et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am. J. Nephrol. 29, 626–632 (2009).
Freedman, B. I. et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int. 75, 736–745 (2009).
Pattaro, C. et al. Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int. 76, 297–306 (2009).
Franceschini, N. et al. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum. Genet. 127, 295–301 (2010).
Freedman, B. I. et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol. Dial. Transplant. 24, 3366–3371 (2009).
Nelson, G. W. et al. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum. Mol. Genet. 19, 1805–1815 (2010).
Behar, D. M. et al. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum. Mol. Genet. 19, 1816–1827 (2010).
Voelker, R. B. & Berglund, J. A. A comprehensive computational characterization of conserved mammalian intronic sequences reveals conserved motifs associated with constitutive and alternative splicing. Genome Res. 17, 1023–1033 (2007).
Yeo, G. W., Van Nostrand, E. L. & Liang, T. Y. Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements. PLoS Genet. 3, e85 (2007).
Ehret, G. B. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr. Hypertens. Rep. 12, 17–25 (2010).
Wyatt, C. M. et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS 21, 2101–2103 (2007).
Ahuja, T. S. et al. Is the prevalence of HIV-associated nephropathy decreasing? Am. J. Nephrol. 19, 655–659 (1999).
Choi, A. I. et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J. Am. Soc. Nephrol. 18, 2968–2974 (2007).
Naicker, S. & Fabian, J. Risk factors for the development of chronic kidney disease with HIV/AIDS. Clin. Nephrol. 74 (Suppl. 1), S51–S56 (2010).
Kopp, J. B., Winkler, C. A. & Nelson, G. W. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Semin. Nephrol. 30, 409–417 (2010).
Behar, D. M., Shlush, L. I., Maor, C., Lorber, M. & Skorecki, K. Absence of HIV-associated nephropathy in Ethiopians. Am. J. Kidney Dis. 47, 88–94 (2006).
Freedman, B. I. et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J. Am. Soc. Nephrol. 21, 1422–1426 (2010).
Vanhollebeke, B. & Pays, E. The function of apolipoproteins L. Cell. Mol. Life Sci. 63, 1937–1944 (2006).
Vanhamme, L. et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83–87 (2003).
Thomson, R., Samanovic, M. & Raper, J. Activity of trypanosome lytic factor: a novel component of innate immunity. Future Microbiol. 4, 789–796 (2009).
Pays, E. & Vanhollebeke, B. Human innate immunity against African trypanosomes. Curr. Opin. Immunol. 21, 493–498 (2009).
Lukeš, J. & Raper, J. Prophylactic antiparasitic transgenesis for human parasitic disease? Mol. Ther. 18, 1745–1747 (2010).
Brun, R., Blum, J., Chappuis, F. & Burri, C. Human African trypanosomiasis. Lancet 375, 148–159 (2010).
Lecordier, L. et al. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog. 5, e1000685 (2009).
De Greef, C., Chimfwembe, E., Kihang' a Wabacha, J., Bajyana Songa, E. & Hamers, R. Only the serum-resistant bloodstream forms of Trypanosoma brucei rhodesiense express the serum resistance associated (SRA) protein. Ann. Soc. Belg. Med. Trop. 72 (Suppl. 1), 13–21 (1992).
Kieft, R. et al. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc. Natl Acad. Sci. USA 107, 16137–16141 (2010).
Oleksyk, T. K., Nelson, G. W., An, P., Kopp, J. B. & Winkler, C. A. Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS ONE 5, e11474 (2010).
Wan, G. et al. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J. Biol. Chem. 283, 21540–21549 (2008).
Monajemi, H., Fontijn, R. D., Pannekoek, H. & Horrevoets, A. J. The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79, 539–546 (2002).
Hartleben, B. et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest. 120, 1084–1096 (2010).
Takemura, T. et al. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int. 43, 918–927 (1993).
Candiano, G. et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 12, 143–150 (2001).
Nogueira, J. M. et al. A study of renal outcomes in African American living kidney donors. Transplantation 88, 1371–1376 (2009).
Lentine, K. L. et al. Racial variation in medical outcomes among living kidney donors. N. Engl. J. Med. 363, 724–732 (2010).
Gibney, E. M., King, A. L., Maluf, D. G., Garg, A. X. & Parikh, C. R. Living kidney donors requiring transplantation: focus on African Americans. Transplantation 84, 647–649 (2007).
Ponticelli, C. & Glassock, R. J. Posttransplant recurrence of primary glomerulonephritis. Clin. J. Am. Soc. Nephrol. 5, 2363–2372 (2010).
Schachter, M. E. et al. Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression. Clin. Nephrol. 74, 173–181 (2010).
Chobanian, A. V. The hypertension paradox–more uncontrolled disease despite improved therapy. N. Engl. J. Med. 361, 878–887 (2009).
Appel, L. J. et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).
Dobzhansky, T. Biology, molecular and organismic. Am. Zool. 4, 443–452 (1964).
Darvasi, A. & Shifman, S. The beauty of admixture. Nat. Genet. 37, 118–119 (2005).
Pritchard, J. K. How we are evolving. Sci. Am. 303, 40–47 (2010).
Schlessinger, S. D., Tankersley, M. R. & Curtis, J. J. Clinical documentation of end-stage renal disease due to hypertension. Am. J. Kidney Dis. 23, 655–660 (1994).
Bianchi, S., Bigazzi, R., Caiazza, A. & Campese, V. M. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am. J. Kidney Dis. 41, 565–570 (2003).
Gbadegesin, R., Lavin, P., Foreman, J. & Winn, M. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr. Nephrol. doi: 10.1007/s00467-010-1692-x.
Löwik, M. et al. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 23, 3146–3151 (2008).
Barisoni, L., Schnaper, H. W. & Kopp, J. B. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin. J. Am. Soc. Nephrol. 2, 529–542 (2007).
Copelovitch, L., Nash, M. A. & Kaplan, B. S. Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 2, 914–918 (2007).
Wyatt, C. M., Klotman, P. E. & D'Agati, V. D. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin. Nephrol. 28, 513–522 (2008).
D'Agati, V., Suh, J. I., Carbone, L., Cheng, J. T. & Appel, G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int. 35, 1358–1370 (1989).
Derebail, V. K. et al. High prevalence of sickle cell trait in African Americans with ESRD. J. Am. Soc. Nephrol. 21, 413–417 (2010).
Freedman, B. I. et al. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am. J. Nephrol. 32, 66–72 (2010).
Frazer, K. A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).
International HapMap Consortium. The International HapMap Project. Nature 426, 789–796 (2003).
International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299–1320 (2005).
Clark, A. G., Hubisz, M. J., Bustamante, C. D., Williamson, S. H. & Nielsen, R. Ascertainment bias in studies of human genome-wide polymorphism. Genome Res. 15, 1496–1502 (2005).
Nordborg, M. & Tavaré, S. Linkage disequilibrium: what history has to tell us. Trends Genet. 18, 83–90 (2002).
Ardlie, K. G., Kruglyak, L. & Seielstad, M. Patterns of linkage disequilibrium in the human genome. Nat. Rev. Genet. 3, 299–309 (2002).
Acknowledgements
K. Skorecki acknowledges the support of the Canadian and American Technion Societies (Eshagian Estate Fund, Dr Sidney Kremer Kidney Disease Research Fund), the Israel Science Foundation (grant number 890015), and the Legacy Heritage Fund. S. Rosset acknowledges the support of European Research Commission grant MIRG-CT-2007-208019, Israel Science Foundation (grant number 1227/09) and an IBM Open Collaborative Research grant. D. M. Behar thanks the European Commission, Directorate-General for Research for FP7 Ecogene grant 205419.
Author information
Authors and Affiliations
Contributions
S. Rosset, S. Tzur, W. G. Wasser and K. Skorecki contributed equally to all aspects of the manuscript. D. Behar made a substantial contribution to discussion of content and review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Figure 1
Modeled structure of the SRA interacting domain of the C-terminus of the APOL1 gene product. (TIFF 225 kb)
Rights and permissions
About this article
Cite this article
Rosset, S., Tzur, S., Behar, D. et al. The population genetics of chronic kidney disease: insights from the MYH9–APOL1 locus. Nat Rev Nephrol 7, 313–326 (2011). https://doi.org/10.1038/nrneph.2011.52
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2011.52
This article is cited by
-
The changing landscape of HIV-associated kidney disease
Nature Reviews Nephrology (2024)
-
Association of preeclampsia with infant APOL1 genotype in African Americans
BMC Medical Genetics (2020)
-
Pharmacotherapy for hypertension in Sub-Saharan Africa: a systematic review and network meta-analysis
BMC Medicine (2020)
-
Survival of HIV infected patients on maintenance hemodialysis in Cameroon: a comparative study
BMC Nephrology (2018)
-
ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus
Current Rheumatology Reports (2017)